Stock 2877 CHINA SHINEWAY PHARMACEUTICAL GROUP LIMITED
Add to a list
To use this feature you must be a member
Log inSign up

All News China Shineway Pharmaceutical Group Limited

Equities

2877

KYG2110P1000

Market Closed - Hong Kong S.E.
Other stock markets
 09:08:39 28/05/2024 BST 		5-day change 1st Jan Change
8.74 HKD -1.58% Intraday chart for China Shineway Pharmaceutical Group Limited -6.72% +20.22%
03-28 China Shineway Pharmaceutical Group Limited Reports Earnings Results for the Full Year Ended December 31, 2023 CI
03-08 China Shineway Pharmaceutical to Log Higher Profit in 2023; Shares Up 3% MT

All News

Search
See the results
Unlock all the news: Be the first to know and act before the market!
100% Free Registration
Ex-dividend day for interim dividend
FA
Final dividend
FA
China Shineway Pharmaceutical Group Grows 2023 Profit, Declares Interim 2024 Dividend
MT
China Shineway Pharmaceutical Group Limited Reports Earnings Results for the Full Year Ended December 31, 2023
CI
China Shineway Pharmaceutical Group Limited Declares First Interim Dividend in Respect of the Year Ending December 31, 2024, Payable on May 17, 2024
CI
China Shineway Pharmaceutical to Log Higher Profit in 2023; Shares Up 3%
MT
China Shineway Pharmaceutical Group Limited Provides Unaudited Consolidated Earnings Guidance for the Year Ended 31 December 2023
CI
​​China Shineway Pharmaceutical Logs 22% Rise in Q1-Q3 Turnover
MT
China Shineway Pharmaceutical Group Limited Announces Resignation of Executive Director
CI
China Shineway Pharmaceutical Group Limited Announces Resignation of Liu Tiejun as Executive Director, Effective 1 November 2023
CI
Ex-dividend day for interim dividend
FA
China Shineway Pharmaceutical’s Profit Rises 48% in H1
MT
China Shineway Pharmaceutical Group Limited Reports Earnings Results for the Half Year Ended June 30, 2023
CI
China Shineway Pharmaceutical Group Limited Proposes Second Interim Dividend in Respect of the Fiscal Year 2023, Payable on 29 September 2023
CI
China BlueChemical, Unit to Invest in Structured Deposit Products
MT
China Shineway Pharmaceutical’s H1 Profit to Rise By Up to 50%
MT
China Shineway Pharmaceutical Group Limited Provides Consolidated Earnings Guidance for the Six Months Ended June 30, 2023
CI
Bank of China Raises 30 Billion Yuan with Bond Issue
MT
Shineway Pharmaceutical's Q1 Turnover Rises 36%
MT
Ex-dividend day for interim dividend
FA
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. 2877 Stock
  4. News China Shineway Pharmaceutical Group Limited